Zierz S, Engel A G
Department of Neurology, Mayo Clinic, Rochester, MN 55905.
Neurology. 1987 Nov;37(11):1785-90. doi: 10.1212/wnl.37.11.1785.
Mitochondria were isolated from rat skeletal muscle, heart, and liver and from human skeletal muscle. The distribution of CPT I and CPT II was studied by measuring CPT activity and malonyl-CoA sensitivity before and after disruption of the mitochondria. Neither sonication, freezing and thawing, nor detergent treatment increased CPT activity in heart or skeletal muscle mitochondria, but these procedures did increase CPT activity in liver mitochondria. These results cannot be attributed to different kinetics of CPT I and II to palmitoyl-CoA or carnitine, or to different effects of electrolytes on CPT I and II. Sensitivity to inhibition by malonyl-CoA also failed to distinguish convincingly between CPT I and II in skeletal muscle. Because the presence of CPT I and II in muscle cannot be ascertained, the notion of a selective CPT I or II deficiency in muscle cannot be entertained.
从大鼠骨骼肌、心脏和肝脏以及人类骨骼肌中分离出线粒体。通过测量线粒体破坏前后的肉碱棕榈酰转移酶(CPT)活性和丙二酰辅酶A敏感性,研究了CPT I和CPT II的分布。超声处理、冻融处理以及去污剂处理均未增加心脏或骨骼肌线粒体中的CPT活性,但这些处理确实增加了肝脏线粒体中的CPT活性。这些结果不能归因于CPT I和II对棕榈酰辅酶A或肉碱的动力学差异,也不能归因于电解质对CPT I和II的不同影响。丙二酰辅酶A对骨骼肌中CPT I和II的抑制敏感性也未能令人信服地区分两者。由于无法确定肌肉中CPT I和II的存在,因此不能考虑肌肉中选择性CPT I或II缺乏的概念。